1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

  • November 2014
  • -
  • Global Data
  • -
  • 142 pages

Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 6
Bacterial Pneumonia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bacterial Pneumonia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Bacterial Pneumonia Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Bacterial Pneumonia 32
Sep 11, 2014: Genocea Commences Phase 2a Trial for GEN-004, Universal Pneumococcal Vaccine Candidate 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Actavis plc 37
Clinical Trial Overview of Actavis plc 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
Cempra, Inc. 39
Clinical Trial Overview of Cempra, Inc. 39
Jacobus Pharmaceutical Company 40
Clinical Trial Overview of Jacobus Pharmaceutical Company 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
U.S. Bioscience, Inc 42
Clinical Trial Overview of U.S. Bioscience, Inc 42
Cubist Pharmaceuticals, Inc. 43
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 43
Bayer AG 44
Clinical Trial Overview of Bayer AG 44
Clinical Trial Overview of Top Institutes / Government 45
The National Institute of Allergy and Infectious Diseases 45
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 45
Pharmaceutical Research Unit, Jordan 47
Clinical Trial Overview of Pharmaceutical Research Unit, Jordan 47
National Heart, Lung, and Blood Institute 48
Clinical Trial Overview of National Heart, Lung, and Blood Institute 48
University of Pittsburgh 49
Clinical Trial Overview of University of Pittsburgh 49
Hospital Universitario Virgen del Rocio 50
Clinical Trial Overview of Hospital Universitario Virgen del Rocio 50
National Taiwan University Hospital 51
Clinical Trial Overview of National Taiwan University Hospital 51
University of Milan 52
Clinical Trial Overview of University of Milan 52
National Institutes of Health Clinical Center 53
Clinical Trial Overview of National Institutes of Health Clinical Center 53
University of Oxford 54
Clinical Trial Overview of University of Oxford 54
National Center for Research Resources 55
Clinical Trial Overview of National Center for Research Resources 55
Five Key Clinical Profiles 56
Appendix 140
Abbreviations 140
Definitions 140
Research Methodology 141
Secondary Research 141
About GlobalData 142
Contact Us 142
Disclaimer 142
Source 142

List of Tables
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bacterial Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Bacterial Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 37
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 38
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2014* 39
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014* 40
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 41
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Bioscience, Inc, 2014* 42
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014* 43
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 44
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 45
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaceutical Research Unit, Jordan, 2014* 47
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 48
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 49
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Virgen del Rocio, 2014* 50
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 51
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014* 52
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014* 53
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014* 54
Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 55

List of Figures
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 141

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

Ulcerative Colitis: Kol Insight

September 2016 $ 8085

Hepatitis C: Kol Insight

September 2016 $ 8085

Download Unlimited Documents from Trusted Public Sources

Therapy Market in Europe

  • November 2016
    19 pages
  • Therapy  

  • Europe  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Therapy Market in the US - Forecast

  • November 2016
    6 pages
  • Therapy  

    Opioid  

  • United States  

View report >

Related Market Segments :

Therapy
Infectious Disease
Clinical Trial
Vaccine

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.